Literature DB >> 18674478

A practical "ABCDE" approach to the metabolic syndrome.

Michael J Blaha1, Sandeep Bansal, Rosanne Rouf, Sherita H Golden, Roger S Blumenthal, Andrew P Defilippis.   

Abstract

The metabolic syndrome comprises a cluster of risk factors for cardiovascular disease and type 2 diabetes mellitus that are due to abdominal obesity and insulin resistance. This increasingly important proinflammatory condition remains both underrecognized and undertreated. To aid physicians in their approach to the metabolic syndrome, we assessed and synthesized the literature on cardiovascular risk assessment and early intervention for risk reduction. We performed a comprehensive search of MEDLINE and the Cochrane database for peer-reviewed clinical studies published from January 1, 1988, to December 31, 2007, augmented by consultation with content experts. We used the search terms metabolic syndrome, abdominal obesity, waist circumference, insulin resistance, cardiovascular disease, prediabetes, diabetes, treatment, prevention, aspirin, hypertension, cholesterol, atherogenic dyslipidemia, lifestyle therapy, diet, and exercise. Criteria used for study review were controlled study design, English language, relevance to clinicians, and validity based on experimental design and appropriateness of conclusions. Although growing evidence supports early intervention in patients with the metabolic syndrome, many physicians do not recognize the risk associated with this condition and fail to initiate early treatment. A comprehensive management plan can be assembled through an "ABCDE" approach: "A" for assessment of cardiovascular risk and aspirin therapy, "B" for blood pressure control, "C" for cholesterol management, "D" for diabetes prevention and diet therapy, and "E" for exercise therapy. This ABCDE approach provides a practical and systematic framework for encouraging metabolic syndrome recognition and for implementing a comprehensive, evidence-based management plan for the reduction of cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18674478     DOI: 10.4065/83.8.932

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  28 in total

1.  Allometric prediction of the human pharmacokinetic parameters for naveglitazar.

Authors:  Preeti Ahlawat; Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Jul-Sep       Impact factor: 2.441

2.  The relevance of inflammatory markers in metabolic syndrome.

Authors:  Genel Sur; Emanuela Floca; Liana Kudor-Szabadi; Maria Lucia Sur; Daniel Sur; Gabriel Samasca
Journal:  Maedica (Buchar)       Date:  2014-03

Review 3.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

4.  Feasibility of the Walk, Address, Learn and Cue (WALC) Intervention for schizophrenia spectrum disorders.

Authors:  Lora Humphrey Beebe; Kathlene Smith
Journal:  Arch Psychiatr Nurs       Date:  2009-08-06       Impact factor: 2.218

5.  Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Michael J Blaha; Juan J Rivera; Matthew J Budoff; Ron Blankstein; Arthur Agatston; Daniel H O'Leary; Mary Cushman; Susan Lakoski; Michael H Criqui; Moyses Szklo; Roger S Blumenthal; Khurram Nasir
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-07       Impact factor: 8.311

6.  Maximal exercise electrocardiographic responses and coronary heart disease mortality among men with metabolic syndrome.

Authors:  G William Lyerly; Xuemei Sui; Timothy S Church; Carl J Lavie; Gregory A Hand; Steven N Blair
Journal:  Mayo Clin Proc       Date:  2010-02-16       Impact factor: 7.616

Review 7.  Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease.

Authors:  Carl J Lavie; Randal J Thomas; Ray W Squires; Thomas G Allison; Richard V Milani
Journal:  Mayo Clin Proc       Date:  2009-04       Impact factor: 7.616

8.  A cross-sectional study of intima-media thickness, ethnicity, metabolic syndrome, and cardiovascular risk in 2268 study participants.

Authors:  Allen Adolphe; Linda S Cook; Xun Huang
Journal:  Mayo Clin Proc       Date:  2009-03       Impact factor: 7.616

9.  Experimental lung injury promotes alterations in energy metabolism and respiratory mechanics in the lungs of rats: prevention by exercise.

Authors:  Maira J da Cunha; Aline A da Cunha; Emilene B S Scherer; Fernanda Rossato Machado; Samanta O Loureiro; Rodrigo B Jaenisch; Fátima Guma; Pedro Dal Lago; Angela T S Wyse
Journal:  Mol Cell Biochem       Date:  2013-12-31       Impact factor: 3.396

10.  Cardiac rehabilitation programs improve metabolic parameters in patients with the metabolic syndrome and coronary heart disease.

Authors:  Ignacio P Pérez; Maria A Zapata; Carlos E Cervantes; Rosario M Jarabo; Cristina Grande; Rose Plaza; Sara Garcia; Miriam L Rodriguez; Silvia Crespo; Jesús Perea
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-05       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.